- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02234973
Transformation of Indigenous Primary Healthcare Delivery (FORGE AHEAD)
Transformation of Indigenous Primary Healthcare Delivery (FORGE AHEAD): Community-driven Innovations and Strategic Scale-up Toolkits
Context: Indigenous peoples experience higher prevalence rates of diabetes and worse health outcomes compared to the general population because of a wide array of factors: social determinants of health, lifestyle, genetic susceptibility, and historic-political and psycho-social factors. Barriers to care that are unique to First Nations communities exacerbate the problem with fragmented healthcare, poor chronic disease management, healthcare staff turnover, and limited, or non-existent, surveillance.
Program: The TransFORmation of IndiGEnous PrimAry HEAlthcare Delivery (FORGE AHEAD) research program aims to develop and evaluate community-driven, culturally relevant, primary healthcare models that enhance chronic disease prevention and management in First Nations communities in Canada. Participants will consist of Indigenous community and clinic team members that will take part in multiple interrelated projects including community profiling, readiness consultations, diabetes registry and surveillance, and quality improvement workshops and action periods.
Design: This mixed-method pre-post observational study will capture: 1) diabetes clinical process and outcomes measures, 2) details about community-driven innovations, and 3) knowledge about the experience and cost of attempting to improve primary delivery in individual Indigenous communities.
Intervention/Instrument: Survey, literature review, 15 month intervention (readiness consultations, implementation and maintenance of a registry and surveillance system, community and clinic focused quality improvement workshops), interviews.
Measures: Primary- mean A1C of patients with diabetes (A1C ≥ 8.0% at baseline); Secondary-clinical process and outcome measures, change in stage of readiness, description of participation and innovation facilitators and barriers.
Policy Implications: The outcomes of this research program have the potential to significantly affect future policy decisions pertaining to chronic disease care in First Nations communities. Policy recommendations will be made to help support Indigenous communities in adopting successful innovations to help address issues related to diabetes and other chronic illnesses. The community-driven innovations developed in FORGE AHEAD and the subsequent policy decisions may enhance chronic disease prevention and management for Indigenous peoples across the country.
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
Ontario
-
London, Ontario, Canada, N6G2M1
- Centre for Studies in Family Medicine, Western University
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Community members
Inclusion Criteria:
- 18 years of age or older
- on-reserve residents of participating Indigenous community partners
Exclusion Criteria:
- less than 18 years of age
- off-reserve residents of participating or non-participating Indigenous community partners
Clinic team members
Inclusion Criteria:
- Health centers of participating Indigenous community partners
- Current type 2 diabetes mellitus registry and surveillance system
Exclusion Criteria:
- Health centers of non-participating Indigenous community partners
- No registry or surveillance system
Diabetes Registry
Inclusion Criteria:
- adults (age≥ 18 years) with type 2 diabetes and most recent HbA1C≥ 8.0%
Exclusion Criteria:
- gestational diabetes, type 1 diabetes, or severe co-morbidity associated with life expectancy <6 months.
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
11 First Nations Community and Clinical Teams
11 Community & Clinical Teams in each First Nation community participated in the intervention.
|
Community and Clinical Teams engaged in implementing Quality Improvement initiatives to improve diabetes prevention and management within their First Nations community and clinic.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
mean HbA1C of patients with diabetes (A1C ≥ 8.0% at baseline)
Time Frame: repeated measures: baseline (12 months prior to the start of the program)
|
repeated measures: baseline (12 months prior to the start of the program)
|
mean HbA1C of patients with diabetes (A1C ≥ 8.0% at baseline)
Time Frame: repeated measures: 6 month after program start date
|
repeated measures: 6 month after program start date
|
mean HbA1C of patients with diabetes (A1C ≥ 8.0% at baseline)
Time Frame: repeated measures: 12 month after program start date
|
repeated measures: 12 month after program start date
|
mean HbA1C of patients with diabetes (A1C ≥ 8.0% at baseline)
Time Frame: repeated measure: 18 months after program start
|
repeated measure: 18 months after program start
|
mean HbA1C of patients with diabetes (A1C ≥ 8.0% at baseline)
Time Frame: repeated measure: 24 months after program start
|
repeated measure: 24 months after program start
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Stewart B Harris, MD, MPH, Western University
Publications and helpful links
General Publications
- Tompkins JW, Mequanint S, Barre DE, Fournie M, Green ME, Hanley AJ, Hayward MN, Zwarenstein M, Harris SB; FORGE AHEAD Program Team. National Survey of Indigenous primary healthcare capacity and delivery models in Canada: the TransFORmation of IndiGEnous PrimAry HEAlthcare delivery (FORGE AHEAD) community profile survey. BMC Health Serv Res. 2018 Nov 1;18(1):828. doi: 10.1186/s12913-018-3578-8.
- Hayward MN, Mequanint S, Paquette-Warren J, Bailie R, Chirila A, Dyck R, Green M, Hanley A, Tompkins J, Harris S; FORGE AHEAD Program Team. The FORGE AHEAD clinical readiness consultation tool: a validated tool to assess clinical readiness for chronic disease care mobilization in Canada's First Nations. BMC Health Serv Res. 2017 Mar 23;17(1):233. doi: 10.1186/s12913-017-2175-6.
- Naqshbandi Hayward M, Paquette-Warren J, Harris SB; FORGE AHEAD Program Team. Developing community-driven quality improvement initiatives to enhance chronic disease care in Indigenous communities in Canada: the FORGE AHEAD program protocol. Health Res Policy Syst. 2016 Jul 26;14(1):55. doi: 10.1186/s12961-016-0127-y.
Helpful Links
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 0000031372
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Type 2 Diabetes Mellitus
-
SanofiCompletedType 1 Diabetes Mellitus-Type 2 Diabetes MellitusHungary, Russian Federation, Germany, Poland, Japan, United States, Finland
-
Mannkind CorporationTerminatedType 2 Diabetes Mellitus | Type 1 Diabetes MellitusUnited States
-
RWTH Aachen UniversityBoehringer IngelheimCompletedDiabetes Mellitus Type 2 (T2DM)Germany
-
Scripps Whittier Diabetes InstituteSan Diego State UniversityCompletedType 2 Diabetes Mellitus (T2DM)United States
-
University Hospital Inselspital, BerneCompletedType 2 Diabetes MellitusSwitzerland
-
India Diabetes Research Foundation & Dr. A. Ramachandran...CompletedTYpe 2 Diabetes MellitusIndia
-
Griffin HospitalCalifornia Walnut CommissionCompletedDIABETES MELLITUS TYPE 2United States
-
US Department of Veterans AffairsAmerican Diabetes AssociationCompletedType 2 Diabetes MellitusUnited States
-
Dexa Medica GroupCompletedType-2 Diabetes MellitusIndonesia
-
AstraZenecaRecruiting
Clinical Trials on Quality Improvement
-
Institute for Clinical Effectiveness and Health...Inter-American Development BankUnknownColorectal NeoplasmsArgentina
-
Sunnybrook Health Sciences CentreCanadian Institutes of Health Research (CIHR); Heart and Stroke Foundation...Completed
-
Duke UniversityNorthwestern University; Wake Forest University Health SciencesCompletedSickle Cell DiseaseUnited States
-
Institute for Clinical Effectiveness and Health...Ministry of Public Health, ArgentinaCompletedCardiovascular Diseases | Quality ImprovementArgentina
-
Dartmouth-Hitchcock Medical CenterConcord Hospital; MGH Multiple Sclerosis Clinic; University of Vermont Multiple... and other collaboratorsCompletedMultiple SclerosisUnited States
-
Brigham and Women's HospitalCompletedGestational Diabetes Mellitus
-
HealthPartners InstituteNovartis; TriHealth Inc.; William Beaumont Hospitals; Advocate Medical Group; Baystate... and other collaboratorsCompleted
-
US Department of Veterans AffairsCompletedSmoking | Smoking Cessation | Quality ImprovementUnited States
-
University of California, DavisCompleted